Pfizer Inc. recalls Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New Y…
- Recall date
- December 6, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0339-2019
- FDA classification
- Class II
- Brand / firm
- Pfizer Inc.
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Superpotent Drug.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Get recall alerts
Free email alert whenever Pfizer Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pfizer Inc.